http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2445076-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_430f5f4924671a260b465b2b00280c6c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate | 2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2317d19ecd9cba00f3ef5d61176db1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fb01fe531bc1e1bf414455ac26a56bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acc846488c1b603be9e7262975aee3d8 |
| publicationDate | 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2445076-C2 |
| titleOfInvention | Method for perftoran ozonation |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry, and medicine, namely transfusiology, and is applicable for ozonation of Perftoran and other foam solutions and emulsions. A method is implemented as follows. Perftoran is bubbled with an ozone-oxygen mixture for 15-20 minutes at 0.5 l/min and at the preset ozone concentration (required, recommended concentration) in any medical ozon plant. It requires making available an original vial (bottle) with Perftoran, a sterile empty vial (bottle) 200, 250 or 400 ml sealed with a rubber cap with an aluminium capsule. The vial with Perftoran shall be coupled with the empty sterile vial through a PVC tube by sticking in needles connected to the tube ends in each vial. In this case, a tube for mixed gas disposal into a destructor does not extend from the vial with Perftoran, but from the second coupled empty vial that prevents Perftoran from the ingress into the desctructor. n EFFECT: method is technically easy-to-implement and allows using ozonised Perftoran both externally in the form of applications or skin wound irrigations, and for introduction in serous cavities for sanation, as well as intravenously. n 1 ex |
| priorityDate | 2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.